EQS-News: Carl Zeiss Meditec AG / Key word (s): Quarterly / Interim Statement/Quarter Results Carl Zeiss Meditec achieves slight revenue growth in first three months of 2024/25 12.02.2025 / 06:58 ...

The global cell counting market, valued at US$10.82 billion in 2023, is forecasted to grow at a robust CAGR of 7.7%, reaching US$11.12 billion ...

Laboratory for Research on the Structure of Matter (LRSM), University of Pennsylvania, Philadelphia, United States ...

We recently published a list of 10 Best Manufacturing Stocks To Buy Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best manufacturing ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against ...

A mirage is not a hallucination. A thirsty desert-walker, thinking she sees a lake ahead, really is seeing something.

Carl Zeiss Meditec reports slight revenue growth of +3.2% in the first three months of fiscal year 2024/25, driven by order entry and order backlog recovery ...